TIRUMALCHM2024-01-012024-03-31 TIRUMALCHM2024-01-012024-03-31 TIRUMALCHM2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member TIRUMALCHM2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member TIRUMALCHM2024-03-31 TIRUMALCHM2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member TIRUMALCHM2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member TIRUMALCHM2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss03Member TIRUMALCHM2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member TIRUMALCHM2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member TIRUMALCHM2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss03Member TIRUMALCHM2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member TIRUMALCHM2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500412 TIRUMALCHM NA Thirumalai Chemicals Limited Equity 2023-04-01 2024-03-31 2024-05-15 2024-05-03 INR Lakhs Yearly 10:30:00 13:55:00 2024-05-15 2024-05-15 true Cash Flow Indirect Declaration of unmodified opinion Single segment Chemical products and its intermediaries 2024-01-01 2024-03-31 Audited Consolidated 5265200000.00 39000000.00 5304200000.00 3846000000.00 112400000.00 318100000.00 197200000.00 98600000.00 165300000.00 753500000.00 5491100000.00 -186900000.00 0.00 -186900000.00 37200000.00 -19400000.00 17800000.00 0.00 -204700000.00 0.00 0.00 0.00 0.00 -204700000.00 -338700000.00 -543400000.00 0.00 0.00 0.00 0.00 102400000.00 1 -2.00 -2.00 0.00 0.00 -2.00 -2.00 1. The Audit Committee has reviewed and the Board of Directors have approved the above results at their respective meetings held on 14 May 2024 and 15 May 2024. 2. In accordance with Ind AS 108, Operating Segments, the Group has identified manufacture and sale of organic chemicals as the only reportable segment. 3. The Standalone and Consolidated financial results have been prepared in accordance with recognition and measurement principles laid down in the Indian Accounting Standard 34, Interim financial reporting (Ind AS 34), prescribed under Section 133 of the Companies Act 2013, the Act, and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of the regulation 33 of the SEBI (Listing obligation and disclosure requirements) Regulations, 2015 as amended. 4. With respect to standalone and consolidated financial results, the figures for the quarter ended 31 March 2024 and 31 March 2023 represent the difference between the audited figures in respect of full financial years and the unaudited figures for the nine months ended 31 December 2023 and 31 December 2022 respectively. 5.The consolidated financial results includes other non-current financial liabilities amounting to Rs. 12,573 lakhs and an equivalent amount in other bank balances. This represents amount received by the step down subsidiary TCL Specialties LLC (TCLS LLC) from West Virginia Economic Development Authority (WVEDA) which is used as a cash collateral and marked as lien against an equivalent interim loan granted by the Huntington Bank. Until the interim loan is repaid, TCLS LLC has no access to or control over the cash collateral amount. The amount received from WVEDA will be converted into a permanent loan from the date of commercial production by TCLS LLC and the interim loan from Huntington Bank will be settled on that date. 6. The board of directors, in its meeting on 15 May 2024, has recommended a final dividend of Rs. 1 per equity share for the financial year ended 31 March 2024. The recommendation is subject to the approval of shareholders at the Annual General Meeting and if approved would result in a cash outflow of approximately Rs. 1,024 lakhs. Single segment 2023-04-01 2024-03-31 Audited Consolidated 20831300000.00 193400000.00 21024700000.00 16699900000.00 161300000.00 -221000000.00 798200000.00 417100000.00 632000000.00 2882700000.00 21370200000.00 -345500000.00 0.00 -345500000.00 110500000.00 -68100000.00 42400000.00 0.00 -387900000.00 0.00 0.00 0.00 0.00 -387900000.00 84400000.00 -303500000.00 0.00 0.00 0.00 0.00 102400000.00 1 11359718000.00 -3.79 -3.79 0.00 0.00 -3.79 -3.79 Other expenses 753500000.00 Other expenses 2882700000.00 5920400000.00 11996100000.00 0.00 1700000.00 1194600000.00 0.00 0.00 0.00 1394100000.00 0.00 0.00 55700000.00 1449800000.00 47500000.00 1254200000.00 21864300000.00 2508300000.00 340700000.00 1831500000.00 4056000000.00 1937900000.00 0.00 57900000.00 8224000000.00 116900000.00 489200000.00 11338400000.00 0.00 0.00 33202700000.00 102400000.00 11359700000.00 11462100000.00 11462100000.00 8125300000.00 0.00 2069600000.00 10194900000.00 147300000.00 709700000.00 0.00 400200000.00 11452100000.00 3507800000.00 5163200000.00 1508700000.00 10179700000.00 75500000.00 24400000.00 8900000.00 0.00 10288500000.00 0.00 0.00 21740600000.00 33202700000.00 417100000.00 687000000.00 -731500000.00 0.00 -68900000.00 -375400000.00 -15500000.00 844900000.00 0.00 449400000.00 0.00 1233300000.00 0.00 632000000.00 0.00 0.00 0.00 -136800000.00 0.00 0.00 73000000.00 105700000.00 0.00 0.00 0.00 0.00 0.00 37500000.00 0.00 2794400000.00 2448900000.00 0.00 0.00 0.00 78400000.00 0.00 2370500000.00 0.00 0.00 0.00 55580000.00 0.00 0.00 0.00 0.00 800000.00 8107400000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 73000000.00 88400000.00 0.00 -227020000.00 0.00 -8227800000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12001600000.00 4959100000.00 0.00 68500000.00 153600000.00 791000000.00 0.00 397400000.00 6426800000.00 569500000.00 72000000.00 641500000.00 3495700000.00 4137200000.00 Re-mesurements of defined benefit plans 800000.00 Equity instruments through other comprehensive income, net -341100000.00 Income tax relating to items that will not be reclassified to profit and loss 39000000.00 Re-mesurements of defined benefit plans -3700000.00 Equity instruments through other comprehensive income, net 15200000.00 Income tax relating to items that will not be reclassified to profit and loss -1700000.00 -301300000.00 9800000.00 0.00 0.00 Exchange differences on translation of foreign operations -37400000.00 Exchange differences on translation of foreign operations 74600000.00 -37400000.00 74600000.00 0.00 0.00